RecruitingN/Aketamine

Ketamine Versus Magnesium Sulfate in the Time and Awakening Quality of General Anesthesia.

Sponsored by University of Sao Paulo General Hospital

NCT ID
NCT04360473
Target Enrollment
140 participants
Start Date
2022-03-14
Est. Completion
2025-12

About This Study

The introduction of the laparoscopic technique for cholecystectomy significantly reduced the incidence and intensity of postoperative pain, with improvement in other markers, such as patient satisfaction, and reduction in hospital stay. However, pain in the postoperative period of laparoscopic cholecystectomy is still a concern that challenges modern anesthesiology. Ketamine and magnesium sulfate are two blockers of N-methyl-D-aspartate (NMDA) receptors with the ability to reduce postoperative pain and postoperative opioid consumption. A frequent concern among anesthesiologists is the quality and time of awakening in patients receiving these medications The main objective of this trial is to compare the quality and time of awakening in patients receiving magnesium sulfate or ketamine. The secondary objective is to compare postoperative analgesia during the postoperative hospital stay. Hypothesis: Our hypothesis is that patients have a faster awakening when they receive magnesium sulfate as an analgesic adjunct, when compared to patients who receive ketamine . Design: this is a prospective, controlled, covered and randomly distributed trial.

Conditions Studied

Awakening, Post-Anesthesia Delayed

Interventions

  • General anesthesia
  • Ketamine plus general anesthesia
  • Magnesium sulfate plus general anesthesia
  • ketamine plus magnesium sulfate plus general anesthesia

Eligibility

Age:18 Years - 70 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* patients scheduled to undergo laparoscopic cholecystectomy, agreement to voluntarily participate in the trial and sign the free and informed consent form.

Exclusion Criteria:

* Coronary disease, ventricular atrial block II or worse, with renal failure , previous history of brain disease, dementia or other psychiatric diseases, and patients with a body mass index\> 35 kg / m² , allergy to any products used in the trial, preoperative use of opioids or corticosteroids.

Study Locations (1)

Hospital da Beneficência Portuguesa de Santos
Santos, São Paulo, Brazil

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

sebastião ernesto
CONTACT
12991457764sebasernesto@gmail.com
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

Ketamine Versus Magnesium Sulfate in the Time and Awakening Quality of General Anesthesia. | Huxley